← Evidence map

ArticleCancer research2014

ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.

Amanda G Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

52 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24385212